We work with the world’s most ambitious pharmaceutical companies, biotechs and academics to accelerate drug discovery through artificial intelligence.
At DeepLife, we enable our partners to leverage the power of our AI discovery platform to unlock biological insights and generate innovative novel treatments for diverse disease domains. We foster partnerships around two forms: assets development or discovery platform partnerships.
Our partners
DeepLife is a biotech company with a mission to build the next generation of system biology. We work in a highly collaborative translational manner, to facilitate the transition of discoveries from laboratory to patients.